SCHEMBL14420143

SCHEMBL14420143

CCCc1cccc(CC(=O)OCOC(=O)Cc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PAM P19021 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
ALOX5 P09917 1/20 0.45
SLC7A5 Q01650 1/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
KAT6A Q92794 1/20 0.42
YWHAG P61981 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRB3 P13945 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14420169 0.91 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1PAMSMN1; SMN2
SCHEMBL14420170 0.91 YWHAG (0.42) ALDH1A1MAPK1L3MBTL1PAMALOX5
SCHEMBL14420100 0.89 SLC7A5 (0.43) ALDH1A1MAPK1L3MBTL1PAMALOX5
SCHEMBL2630609 0.87 PPARA (0.51) ALDH1A1MAPK1L3MBTL1PAMSMN1; SMN2
SCHEMBL14420204 0.87 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1PAMSMN1; SMN2
SCHEMBL14420123 0.82 SLC7A5 (0.57) ALDH1A1TSHRSLC7A5MAPTLMNA
SCHEMBL14420220 0.82 PPARA (0.47) ALDH1A1MAPTLMNAYWHAGMTNR1A
SCHEMBL14420107 0.81 PPARA (0.46) ALDH1A1SLC7A5MAPTLMNAYWHAG
SCHEMBL11633852 0.81 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1PAMTSHR
SCHEMBL18331645 0.80 ALDH1A1 (0.63) ALDH1A1MAPK1L3MBTL1PAMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225303-A1 8-Oxoadenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225303-A1 8-Oxoadenine Compound TLR7, CCR8, TLR8 ALDH1A1 1017/4885MAPK1 2737/4885L3MBTL1 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.